ArticleThe Journal of infectious diseases2022

Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.

Robert A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.